Hodgkin's Lymphoma News and Research

Latest Hodgkin's Lymphoma News and Research

GSK and University of Leicester team up to develop novel drugs to treat blood cancer

GSK and University of Leicester team up to develop novel drugs to treat blood cancer

Study reports BV therapy may be curative in some Hodgkin lymphoma patients

Study reports BV therapy may be curative in some Hodgkin lymphoma patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Everolimus combined with standard R-CHOP therapy shows promise in treating DLBCL patients

Autologous stem cell transplant safe, effective for HIV-associated lymphoma patients

Autologous stem cell transplant safe, effective for HIV-associated lymphoma patients

Researchers find link between obesity and disease relapse in pediatric Hodgkin lymphoma patients

Researchers find link between obesity and disease relapse in pediatric Hodgkin lymphoma patients

Nivolumab drug shows better response rate in metastatic bladder cancer patients

Nivolumab drug shows better response rate in metastatic bladder cancer patients

Initiatives to improve adolescent, young adult cancer outcomes justified

Initiatives to improve adolescent, young adult cancer outcomes justified

Sylvester researchers test new KTE-C19 therapy for patients with aggressive non-Hodgkin's lymphoma

Sylvester researchers test new KTE-C19 therapy for patients with aggressive non-Hodgkin's lymphoma

NCCN publishes series of patient education materials for Non-Hodgkin's Lymphoma

NCCN publishes series of patient education materials for Non-Hodgkin's Lymphoma

Gut bacteria linked to risk of bloodstream infections after chemotherapy

Gut bacteria linked to risk of bloodstream infections after chemotherapy

Novel combination of cancer drugs can have therapeutic impact on diffuse large B-cell lymphoma

Novel combination of cancer drugs can have therapeutic impact on diffuse large B-cell lymphoma

MicroRNA controls tumor cell proliferation in most aggressive large B-cell lymphoma

MicroRNA controls tumor cell proliferation in most aggressive large B-cell lymphoma

Secondary non-Hodgkin's lymphoma a concern for CML patients using TKIs

Secondary non-Hodgkin's lymphoma a concern for CML patients using TKIs

Early screening with MRIs can reduce risk of breast cancer mortality for survivors of childhood HL

Early screening with MRIs can reduce risk of breast cancer mortality for survivors of childhood HL

Researchers launch clinical trials to test novel cellular-immunotherapy to treat three types of blood cancer

Researchers launch clinical trials to test novel cellular-immunotherapy to treat three types of blood cancer

Higher body weight, taller stature during adolescence increase NHL risk

Higher body weight, taller stature during adolescence increase NHL risk

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

Young African Americans, Hispanics fare worse when faced with Hodgkin lymphoma

Young African Americans, Hispanics fare worse when faced with Hodgkin lymphoma

African-American pediatric lymphoma patients have inferior outcomes compared to white and Hispanic peers

African-American pediatric lymphoma patients have inferior outcomes compared to white and Hispanic peers

New study finds significant racial disparity in patients with HIV and Hodgkin lymphoma

New study finds significant racial disparity in patients with HIV and Hodgkin lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.